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Abstract 
 
Erythrina plants, locally known as “dadap ayam”, are higher plant species and have been 
used as a folk medicine for treatment of cancer. To prove the effectiveness of the leaves and 
stem bark of E. variegata as an anti-cancer agent, the assay in this research was focused on in 
vitro test towards breast cancer cell T47D. In the course of our continuing search for novel 
anti-cancer agent from Erythrina plants, the methanol extract of the leaves and stem bark of E. 
variegata showed significant anti-cancer activity against breast cancer cell T47D in vitro using 
the Sulphorhodamine B (SRB) assay. By using the anti-cancer activity to follow the separations, 
the methanol extract was separated by combination of column chromatography. The chemical 
structure of an anti-cancer compounds were determined on the basis of spectroscopic 
evidence and comparison with the previously reported and identified as an erythrina alkaloid 
(1) and isoflavonoid (2). Compounds (1-2) showed anti-cancer activity against breast cancer 
cell T47D used with IC50 of 1.0 and 3.3 µg/mL, respectively. This results strongly suggested that 
E. variegata is promising sources for anti-cancer agents.  
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INTRODUCTION 
 
Breast cancer is the most commonly 
diagnosed invasive non-skin malignancy and 
second leading cause (after lung cancer) of cancer 
related deaths in the women. Both epidemiological 
and laboratory studies show that environmental 
and behavioral factors are more important than 
genetic factors in determining overall cancer 
frequency among populations. Currently, systemic 
cytotoxic chemotherapy approaches, controlling 
and treating breast cancer, are being used; which 
are not only less effective but are also non-
selective and highly toxic to normal tissues (Tyagi 
et al., 2004). Cisplatin is an anticancer drug that 
has enjoyed remarkable success against testicular 
tumor, but dose limiting side-effects have limited 
its application against a broader range of cancer. 
An approach that is gaining attention in recent 
years is combination chemotherapy, where non-
toxic or less toxic phytochemicals are being 
combined with chemotherapy agents to enhance 
the efficacy together with a reduced toxicity to 
normal tissues (Tyagi et al., 2002).  
The search for anti-cancer medicinal plant depends 
on the accurate and specific ethno-botanical and 
ethno-pharmacological information obtained from 
the reference document. Recently, attention was 
focused on medicinal plants to provide new anti-
cancer agents. E. variegata (Leguminosae) is a 
famous medicinal plant widely distributed in 
tropical and subtropical region of the world. This 
plant is locally known as “dadap ayam” in 
Indonesia and the leaves of   E. variegata are used 
as an anti-cancer agent (Heyne, 1987).  
Previous studies have shown that the leaves 
of E. variegata contains alkaloids and flavonoids, 
which are unknown to display interesting 
biological activities (Chawla et al., 1987; Tanaka 
et al., 1988; 2000; 2002; 2003; Herlina et al., 
2008).  
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Pharmacological report that steroid 
derivates from the stem bark and the leaves of E. 
variegata showed an anti-cancer against on breast 
cancer cell T47D in vitro (Herlina, 2009). As part 
of our continuing search for novel anti-cancer 
compound from Indonesia Erythrina plants, we 
report here with the isolation, structure elucidation 
and anti-cancer activity.    
 
MATERIALS AND METHODS 
 
General Experimental Procedure 
Melting points were uncorrected. The IR 
spectra were recorded with a Perkin-Elmer 1760 X 
FT-IR spectrophotometer, and the UV spectra 
were recorded with a Hitachi model U-3210. Mass 
spectra were recorded with JEOL JMS-DX300 
instrument. The 
1
H- and 
13
C-NMR spectra were 
obtained with JEOL JNM GX 270 and JNM A-500 
spectrometer. Chemical shifts are given on a δ 
(ppm) scale with TMS as an internal standard. 
Column chromatography was carried out using 
Merck Kieselgel 60 (70-200 mesh), and  thin layer 
chromatography (TLC) analysis was performed on 
precoated  Si Gel plates (Merck Kieselgel GF254, 
0.25 mm 20 x 20 cm). 
 
Plant material 
Samples of the stem bark and the leaves of 
E. variegata was collected on June 2008, in 
Bandung District, West Java, Indonesia. The plant 
was identified by a staff at the Laboratory of Plant 
Taxonomy, Department of Biology, Bandung 
Institute of Technology, Bandung, Indonesia, and a 
voucher specimen has been deposited at the 
herbarium. 
 
Anti-cancer Assay 
National Cancer Institute developed an in 
vitro anticancer-drug method with the SRB 
(Sulforhodamine B) assay. This method measures 
the cellular protein content of adherent and 
suspension cultures in 96-well microtiter plates. 
Cultures fixed with trichloro acetic acid (TCA) are 
stained with 0.4% SRB dissolved in 1% acetic 
acid. Unbounded dye is removed by washing with 
1% acetic acid, and protein-bound dye is extracted 
with 10 mM buffered tris base [tris 
(hydroxymethyl) amino methane] for the 
determination of optical density (515 nm) with a 
96-well microtiter plate reader. Cisplatin 
functioned well as positive controls (Skehan et al., 
1990).  
 
 
Extraction and isolation 
The dried leaves (2 kg) of E. variegata were 
soaked in MeOH. Evaporation of the MeOH gave 
an aqueous concentrate, which was extracted with 
CH2Cl2. The resulting CH2Cl2 extract was 
partitioned between n-hexane and MeOH 
containing 10% water, and then the lower layer 
was concentrated and extracted with EtOAc to 
efford residue (36.31 g). The methanol layer was 
partitioned between n-butanol-water (3:1).   The n-
butanol layer was subsequently dried over 
anhydrous sodium sulfate, filtered, evaporated to 
dryness, and assayed for anti-malarial activity. The 
n-butanol fraction (4 g) was chromatographed on 
Kieselgel 60 (70-230 mesh) by eluting with 
chloroform-ethyl acetate in an increasing ratio 
(1:1-1:5) to yield a 3 fractions (BA, BB, and BC). 
The BC fraction (1.5 g) was eluted with 
chloroform and 5% acetic acid were further flash-
chromatographed on Kieselgel 60 to yield an 
isolate 1 (53 mg).      
The dried stem bark (2.2 kg) of E. variegata 
was extracted by maceration technique three times 
with methanol. The crude methanolic extract was 
then assayed for antimalarial activity via the LDH 
method. Evaporation of the methanol extract gave 
concentrated aqueous extract, which was extracted 
with dichloromethane. The resulting 
dichloromethane extract was partitioned between 
n-hexane and methanol containing 10% water, and 
then lower layer was concentrated and extracted 
with ethyl acetate. The ethyl acetate layer was 
subsequently dried over anhydrous sodium sulfate, 
filtered, evaporated to dryness, and assayed for 
anti-malarial activity. The ethyl acetate fraction 
(15.8 g) was chromatographed on Kieselgel 60 
(70-230 mesh) by eluting with n-hexane and an 
increasing ratio of ethyl acetate, and by ethyl 
acetate and an increasing ratio of methanol to 
afford the 20% methanol eluate (1.2 g). The 
fraction (683 mg) eluted with 10% and 20% 
methanol were further flash-chromatographed on 
Kieselgel 60 with 5% methanol in chloroform to 
yield a crude active compound (191 mg), which 
were crystallized from methanol to yield active 
compounds   (21.3 mg) and 2 (25.5 mg).                  
      
RESULTS AND DISCUSSION 
 
The methanolic extract of dried of the 
leaves and stem bark of E. variegata exhibited an 
anti-cancer activity against breast cancer T47D cell 
in vitro using the SRB method. The active 
methanol extract was partitioned between n-
hexane, ethyl acetate, and n-butanol to afford an 
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active ethyl acetate and n-butanol. By using the 
SRB method to follow the separations, the ethyl 
acetate and n-butanol fraction were separated by 
combination of column chromatography on 
Kieselgel 60 to afford a two active isolates (1 and 
2). 
The isolate 1 was obtained as a  yellow pale 
needless crystal, m p 72-74 
0
C; UV (CHCl3) λmax 
(ε)  288 (4,500), 350 (50) nm; IR (KBr) max 3433, 
2931, 1654, 1593, and 779 cm
-1
; 
1
H NMR (CDCl3, 
400 MHz)  7.47 (1H, s, H-17),  7.26 (1H, s, H-
14), 6.04 (1H, br d,  J = 4.4, H-1), 4.40 (1H, t, J = 
5,1, H-2), 4.32 (1H, m, H-8a), 3.98 (3H, s, OCH3-
16),    3.95 (3H, s, OCH3-15), 3.42 (1H, td, J = 
10,0; 6,3; H-8b), 3.35 (1H, td, J = 12.1; 4,8;     H-
3), 3.16 (3H, s, OCH3-3), 2.53 (2H, m, H-7), 2.15 
(1H, dd, J = 12,1, H-4eq),  2.08   (1H, dd, J = 11,7; 
4,8; H-4ax); 
13
C NMR (CDCl3, 100 MHz)  180.3 
(C-11),     159.1 (C-10), 149.3 (C-16), 141.6 (C-6), 
139.1 (C-13), 125.5 (C-1), 124.3 (C-12),      110.3 
(C-17), 107.7 C-14), 81.5 (C-3), 72.6 (C-2), 64.7 
(C-5), 57.2 (OCH3-3), 56.5 (OCH3-16), 56.3 
(OCH3-15), 46.9 (C-4), 46.1 (C-8), 31.3 (C-7); 
EIMS m/z 359. 
The isolate 2 was obtained as colourless 
needles crystal, mp 150-152
o
C; UV (CHCl3) λmax 
(ε)  286 (16.000), 222 (80) nm; IR (KBr) max 
3375, 2922, 1620, and 758 cm
-1
; 
1
H NMR (CDCl3, 
500 MHz) [δH 3.80 (3H, s)]; [δH 1.47 (6H, s)], [δH 
3.90 (1H, H-6eq)]; δH 4.20 (1H, H-6ax); δH 5,23 
(1H, H-11a); [δH 3.30 (2H, H-1’); δH 3.20 (2H, H-
1”)]; [δH 5.31 (1H, H-2’)]; [δH 5.27 (1H, H-2”)]. 
13
C NMR (CDCl3, 125 MHz) (δc 56.10), (δc 28), 
[δc 154 (C-4a) and 158.6 (C-1)]; δc 69.7, δc 69.7, 
δc 84.4, δc 29.4, δc 22.6, δc 121.9, δc 122.1. The 
HMBC and 
1
H-
1
H COSY spectra of isolate 2 are 
illustrated in Fig.1.  
 
Anti-cancer activity of extract, fraction, and 
isolates 
The percentage inhibition of methanol 
extract, ethyl acetate, n-butanol fraction and, 
isolates (1 and 2) against breast cancer cell T47D 
can be described to be in the following that isolate 
1 (IC50 1.0 µg/mL) higher than isolate 2, n- butanol 
fraction (IC50 10.5 µg/mL), ethyl acetate fraction 
(IC50 22.9 µg/mL), and methanol extract (IC50 
43.7µg/mL) (Table I). 
 
Tabel I. IC50 values of methanol extract, ethyl acetate fraction, n-butanol fraction, and isolates 
obtained against breast cancer cell T47D 
Sample IC50 (µg/ml) 
Methanol extract of the leaves 
Methanol extract of the stem bark 
43.7 
40.5 
Ethyl acetate fraction of the stem bark 22.9 
n- butanol fraction of the leaves 
erystagallin A (1) 
10.5 
3.3 
10,11-dioxoerythratidine (2) 1.0 
Cisplatin 3.2 
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Figure 1. The HMBC and 1H-1H COSY spectra of isolates (1 and 2) 
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The isolate 1 was obtained as a yellow pale 
needless crystal, m p 72-74 
0
C. The molecule 
formula was established to be C19H21NO6 by 
1
H-
and 
13
C-NMR spectral data, thus requiring ten 
degrees of unsaturation. Its UV spectrum of isolate 
showed aryl and carbonyl absorption at 288 and 
350 nm, respectively. The IR spectrum of 
compound isolate displayed some characteristic 
absorption for an aromatic ring, hydroxyl and 
carbonyl group. The 
1
H-NMR and 
13
C-NMR 
spectra of isolate showed signals assignable to a 
1,2,4,5-tetrasubtituted benzene ring [δH 7.02 (1H,s) 
and 7.47 (1H,s)] and [δC 107.8; 110. 4; 124. 3; 
139. 2; 149.3; and 153.1] and two carbonyl groups 
[δC 160.0 and 180.4] ppm, indicating isolate to be 
a tetracyclyc structure. Three methoxyls were also 
observed in the 
1
H-NMR and 
13
C-NMR spectra [δH 
3.16 (3H, s); 3.95 (3H, s) and 3.98 (3H, s)] and [δC 
57.2; 56.3 and 56.5]. To determine the 
connectivity of the partial structure, 
1
H-
1
H COSY, 
HMBC, and NOESY experiment for isolate was 
carried out, and the results are shown in Fig. 1. 
The NOESY spectra showed signals assignable to 
α-configurated equatorial of H-1, H-2, H-3, H-4, 
H-7, and H-8, while of 2-OH, 3-OCH3, H-4, H-7, 
H-8, H-14, 15- OCH3,  16- OCH3,  and H-17 are β-
configurated axial. The based on the spectral 
spectroscopic evidence, comparison with the 
previously reported and biogenetic point of view, 
the genus Erythrina seems to lack biogenetic 
ability to produce alkaloids (Chawla et al, 1987; 
Supratman et al., 2002) identified as 10,11-
dioxoerythratidine.  
The isolate 2, obtained as colourless needles 
crystal, mp 150-152
o
C, was shown to have a 
molecular formula of C26H30O5 based on 
1
H-and 
13
C-NMR (CDCl3, 500 and 125 MHz) spectral 
data with twelve double bond equivalents. The UV 
absorption maxima of 2 in MeOH at 286 nm (ε 
16.000) and 222 nm (ε 80), suggested the presence 
of a flavonoid skeleton. IR absorption bands due to 
a hydroxyl and an aromatic ring were observed at 
3375, 2922, 1620, and 758 cm
-1
, respectively. The 
1
H-NMR and 
13
C-NMR in combination with 
DEPT spectra of 2 showed signals assignable to a 
methoxyl group [δH 3.80 (3H, s);  δc 56.1], a 
hydoxyl group [δH 1.47 (6H, s); δc 28], two 
oxycarbons [δc 154 (C-4a) and 158.6 (C-1)], three 
protons [δH 3.90 (1H, H-6eq)]; δc 69.7, δH 4.20 
(1H, H-6ax); δc 69.7, and δH 5,23 (1H, H-11a); δc 
84.4], and four protons  [δH 3.30 (2H, H-1’); δc 
29.4,  δH 3.20 (2H, H-1”); δc 22.6, δH 5.31 (1H, H-
2’); δc 121.9, δH 5.27 (1H, H-2”); δc 122.1], 
respectively, indicating that 2 to be pterocarpan 
derivative  having two isoprenyl groups. The 
HMBC spectra of 2 showed correlations proton H-
4 (δH  6.38) with C-2 (δC 121.6), between proton 
H-1' (δH 29.4) with C-2 (δC 121.6) and C-3 (δC 
155.7), between proton H-6ax (δH 3.90) with C-4a 
(δC 154.2) and C-11a (δC 158.6), and proton H-8 
(δH 6.49) with C-6b (δC 120.6), respectively, 
indicating the position of hydroxyl groups at C-3 
and C-6a. The correlation proton H-8 (δH 6.49) 
with C-9 (δC 159.9), indicating that methoxyl 
group at position C-9.  Furthermore the correlation 
between proton H-1’ (δH 3.30) with C-1 (δC 132.2) 
and C-2 (δC 121.6), and H-1” (δH 3.20) with C-10 
(δC 113.7), indicating the position of isoprenyl 
groups at C-2 and C-10. The HMBC and 
1
H-
1
H 
COSY spectra of isolate 2 are illustrated in Fig.1. 
These observations together with a detailed 
comparison of there spectral data with those 
previously reported led us to identify the isolate 2 
as erystagallin A (Tanaka et al., 1988). 
The potency of methanol extract, ethyl 
acetate fraction, and 10,11-dioxoerythratidine 
against breast cancer T47D cell can be described to 
be in the following order; 10,11-dioxoerythratidine 
> erystagallin A > n-butanol fraction > ethyl 
acetate fraction > methanol extract, indicated that   
10,11-dioxoerythratidine and erystagallin A  to be 
potential as an anti-cancer agents.    
 
CONCLUSION 
 
The 10,11-dioxoerythratidine (1) and the 
crystagallin A (2) had been isolated from the 
leaves and stem bark of E. variegata. Our results 
strongly suggested that both compounds (1-2) are 
promising as anti-cancer agents. 
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